Six-minute walk test is reliable and sensitive in detecting response to therapy in CIDP.
Emanuele SpinaAntonietta TopaRosa IodiceStefano TozzaLucia RuggieroRaffaele DubbiosoMarcello EspositoPasquale DolceLucio SantoroFiore ManganelliPublished in: Journal of neurology (2019)
The combination of the 6MWT with the other clinical measures increased the chance to detect the quote of responders. We propose to include the 6MWT in the routine assessment of CIDP patients and the MCID cutoff at 20 m could be set for identifying the responders and properly guiding the therapy management.